Cutler Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-200
| Closed | -$6K | – | 1509 |
|
|
2023
Q4 | $6K | Sell |
200
-700
| -78% | -$21K | ﹤0.01% | 1066 |
|
|
2023
Q3 | $28K | Buy |
900
+500
| +125% | +$15.6K | ﹤0.01% | 810 |
|
|
2023
Q2 | $16K | Hold |
400
| – | – | ﹤0.01% | 873 |
|
|
2023
Q1 | $14K | Sell |
400
-100
| -20% | -$3.5K | ﹤0.01% | 929 |
|
|
2022
Q4 | $17K | Sell |
500
-6,000
| -92% | -$204K | ﹤0.01% | 1143 |
|
|
2022
Q3 | $363K | Buy |
6,500
+1,500
| +30% | +$83.8K | 0.02% | 338 |
|
|
2022
Q2 | $258K | Buy |
5,000
+306
| +7% | +$15.8K | 0.02% | 406 |
|
|
2022
Q1 | $341K | Buy |
4,694
+4,494
| +2,247% | +$326K | 0.02% | 431 |
|
|
2021
Q4 | $23K | Sell |
200
-140
| -41% | -$16.1K | ﹤0.01% | 1438 |
|
|
2021
Q3 | $45K | Sell |
340
-8,860
| -96% | -$1.17M | ﹤0.01% | 1245 |
|
|
2021
Q2 | $1.49M | Buy |
+9,200
| New | +$1.49M | 0.07% | 186 |
|
|
2018
Q3 | – | Sell |
-1,362
| Closed | -$37K | – | 2008 |
|
|
2018
Q2 | $37K | Sell |
1,362
-2,700
| -66% | -$73.3K | ﹤0.01% | 974 |
|
|
2018
Q1 | $85K | Buy |
4,062
+2,864
| +239% | +$59.9K | 0.01% | 788 |
|
|
2017
Q4 | $23K | Sell |
1,198
-3,278
| -73% | -$62.9K | ﹤0.01% | 1348 |
|
|
2017
Q3 | $111K | Buy |
4,476
+2,355
| +111% | +$58.4K | ﹤0.01% | 967 |
|
|
2017
Q2 | $33K | Buy |
+2,121
| New | +$33K | ﹤0.01% | 1653 |
|